[CrossRef] [PubMed] [Google Scholar] A review of current evidence for acetyl-l-carnitine in the treatment of depression
If youre a benefit leader navigating GLP-1 strategy, you should join us: Register here: PS
However, these correlations are not complete
Maruyama T, Maruyama N, Higuchi T, Nagura C, Takashima H, Kitai M, et al
Monitoring of volume status and renal parameters is advisable Poorly controlled hypertension , where the interaction between retatrutide and existing antihypertensive regimens may be unpredictable A history of pancreatitis : in line with UK Summary of Product Characteristics (SmPC) wording for approved GLP-1-based therapies such as semaglutide (Wegovy) and tirzepatide (Mounjaro), retatrutide should be used with caution in patients with a history of pancreatitis, and discontinued promptly if acute pancreatitis is suspected Thyroid C-cell tumours : rodent studies with GLP-1 receptor agonists have identified C-cell hyperplasia and tumours
Small extracellular vesicles have GST activity and ameliorate senescence-related tissue damage
